AIM
APYX icon

Acrospire Investment Management’s Apyx Medical APYX Stock Holding History

Acrospire Investment Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,059
Closed -$17K – 90
2017
Q2 		$17K Sell
7,059
-1,649
-19% -$4.05K 0.02% 1604
2017
Q1 		$23K Sell
8,708
-5,923
-40% -$19.7K 0.02% 1535
2016
Q4 		$53K Buy
+14,631
New +$65.2K 0.02% 1358

Other funds holding APYX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
HK
Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acrospire Investment Management's APYX Position: Q3 2017 in Review

Acrospire Investment Management sold out of Apyx Medical (APYX) in Q3 2017, closing a stake of 7,059 shares — an estimated $17K sold.

Acrospire Investment Management first reported a position in APYX in Q4 2016 and held it in 3 quarters. The position peaked at $53K in Q4 2016. 39 funds tracked by Wall St. Rank hold APYX as of Q3 2017.

  • Acrospire Investment Management reported no remaining Apyx Medical position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 7,059 Apyx Medical shares in Q3 2017, an estimated $17K.
  • Acrospire Investment Management first reported a position in Apyx Medical in Q4 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Apyx Medical position peaked at $53K in Q4 2016.
  • 39 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.